Overview

This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091

Status:
Terminated
Trial end date:
2020-12-08
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine the biodistribution and intra-tumor accumulation of [89Zr]Zr-BI 754111 at baseline and its change upon treatment
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim